Digimarc Corporation (DMRC) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline — Neutral
DMRC Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=151990&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Launches Fraud Investigation on Behalf of Eos Energy Enterprises, Inc. (EOSE) Shareholders — Neutral
EOSE Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eos Energy Enterprises, Inc. ("Eos Energy Enterprises, Inc.") (NASDAQ:EOSE) concerning possible violations of federal securities laws. Eos disclosed in a filing with the U.S. Securities and Exchange Commission on May 27, 2025, that it had "terminated the employment of its Chief Financial Officer (‘CFO'), Eric Javidi, effective immediately.

Lost Money on Rocket Companies, Inc. (RKT)? Urged to Join Class Action Before July 8, 2025 - Contact Levi & Korsinsky — Neutral
RKT Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=152006&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Iovance Biotherapeutics, Inc. (IOVA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 14, 2025 Deadline — Neutral
IOVA Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=152005&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

June 30, 2025 Deadline Approaching: Join Class Action Against Open Lending Corporation (LPRO) - Contact Levi & Korsinsky — Neutral
LPRO Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=152004&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Tesla shares jump 5% after all-out Trump-Musk feud wipes out $150B market value — Positive
TSLA New York Post — June 06, 2025Investors were hopeful for signs that the two might reconcile after Tesla suffered its worst single-day drop in more than four years, though President Trump said Friday he has no interest in a call with CEO Elon Musk.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT — Neutral
PTCT GlobeNewsWire — June 06, 2025NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cable One, Inc. - CABO — Neutral
CABO GlobeNewsWire — June 06, 2025NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. - CAPR — Neutral
CAPR GlobeNewsWire — June 06, 2025NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Will an Innovative Game Pipeline Drive TTWO's Net Bookings Growth? — Positive
TTWO Zacks Investment Research — June 06, 2025Take-Two Interactive rides a 17% bookings surge as demand for Grand Theft Auto, NBA 2K and new titles fuels its growth outlook.

Volaris Reports Decrease in Consolidated Load Factor for May — Negative
VLRS Zacks Investment Research — June 06, 2025Volaris witnesses a lower May load factor as capacity outpaced demand, despite carrying 2.5 million passengers, up 4.2% year over year.

FuelCell Energy, Inc. (FCEL) Q2 2025 Earnings Call Transcript — Neutral
FCEL Seeking Alpha — June 06, 2025FuelCell Energy, Inc. (NASDAQ:FCEL ) Q2 2025 Earnings Conference Call June 6, 2025 10:00 AM ET Company Participants Jason B. Few - President, CEO & Director Michael S.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Metallus Inc. - MTUS — Neutral
MTUS GlobeNewsWire — June 06, 2025NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. (“Metallus” or the “Company”) (NYSE: MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED — Neutral
GMED GlobeNewsWire — June 06, 2025NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

ASML: Not Even The Geopolitical Storm Can Stop This Machine — Negative
ASML Seeking Alpha — June 06, 2025ASML is currently in the eye of a geopolitical storm, facing potential hiccups through tensions between the U.S., the EU, China and Taiwan. Despite these headwinds ASML is currently offering upside potential of up to 63%. Even when considering no more future business in China, the company is currently trading in the fair value range.

7% Yield From LXP Industrial Trust And Its Preferred Stock — Positive
LXP Seeking Alpha — June 06, 2025Spreads on REIT preferreds have improved, making high-quality options like LXP Industrial Trust's preferred shares attractive again. LXP boasts a strong, diversified portfolio of Class A industrial properties, solid financials, and high asset coverage ratios. Our credit analysis assigns LXP's preferred shares LXP.PR.C a Baa3 rating, indicating good creditworthiness despite the lack of agency ratings.

Crude Oil Price Forecast – Crude Oil Rallies After NFP — Positive
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP FXEmpire — June 06, 2025The crude oil market continues to see a lot of noisy behavior, as the Non-Farm Payroll announcement came out hotter than anticipated, and since the crude oil market higher due to the idea of anticipated demand picking up.

Waldencast is a fast-growing beauty company with strong brands (Milk Makeup, Obagi), but faces margin pressure and negative earnings due to high SG&A and debt. Recent revenue growth remains solid, but Q1 FY25 saw a sales dip, especially in Milk Makeup, due to international headwinds and inventory adjustments. The company's financials are typical for a high-growth firm: negative cash flow, high leverage, but manageable liquidity, and a long debt runway until 2030.

Nonfarm Payrolls Increased More Than Expected — Neutral
ADP Zacks Investment Research — June 06, 2025We've experienced an abnormally newsworthy week for the stock market, but arguably this morning brings us the biggest news of all: the May Employment Situation report from the U.S. Bureau of Labor Statistics (BLS). Headline jobs growth came in at +139K — +14K higher than the +125K anticipated.

AECOM Stock Trades at a Discount: Should Investors Buy It Yet? — Positive
ACM Zacks Investment Research — June 06, 2025Healthy backlog, favorable market trends and discounted valuation make ACM an attractive pick.
